| Literature DB >> 26937249 |
Gary M Marsh1, Peter Morfeld2, Sarah D Zimmerman1, Yimeng Liu1, Lauren C Balmert1.
Abstract
BACKGROUND: To determine whether the National Cancer Institute's (NCI) suggestion of a persistent increased mortality risk for nasopharyngeal cancer (NPC) in relation to formaldehyde (FA) exposure is robust with respect to alternative methods of data analysis.Entities:
Keywords: Cohort mortality study; Formaldehyde; Nasopharyngeal cancer; National Cancer Institute; Occupational health; Reanalyses
Year: 2016 PMID: 26937249 PMCID: PMC4774098 DOI: 10.1186/s12995-016-0097-6
Source DB: PubMed Journal: J Occup Med Toxicol ISSN: 1745-6673 Impact factor: 2.646
Selected characteristics and findings for 10 plants in 2004 update of NCI formaldehyde cohort study
| UPitt (NCI) plant no. | 1 (1) | 2 (2) | 3 (3) | 4 (5) | 5 (6) | 6 (7) | 7 (8) | 8 (10) | 9 (11) | 10 (12) |
|---|---|---|---|---|---|---|---|---|---|---|
| Entry year | 1943 | 1945 | 1949 | 1958 | 1957 | 1951 | 1938 | 1934 | 1956 | 1941 |
| No. Subjects | 4261 | 784 | 2375 | 1692 | 744 | 5248 | 4228 | 1679 | 1933 | 2675 |
| Formaldehyde exposure | ||||||||||
| % Subjects ever exposed | 87.7 | 99.9 | 92.7 | 93.3 | 64.4 | 91 | 81.6 | 99.3 | 88.2 | 95 |
| % Subjects ever in highest peak category | 46.1 | 91.6 | 0 | 72.9 | 20.4 | 2 | .4 | 1.1 | 9.3 | 69.7 |
| Median AIE (ppm) a | 1.023 | 2.799 | .112 | .234 | .196 | .233 | .080 | .382 | .400 | .543 |
| (5–95 %-tile) | .310–1.417 | .300–3.927 | .010–.222 | .100–.596 | .029–1.132 | .033–.868 | .020–.250 | .100–2.000 | .100–1.615 | .216–1.124 |
| Median Cum (ppm-years) a | .9 | 19.0 | .1 | 2.2 | 1.9 | .7 | .1 | .6 | .3 | 1.3 |
| (5–95 %-tile) | .1–17.2 | .4–86.5 | .01–2.1 | .06–11.9 | .08–27.5 | .01–16.3 | .01–3.5 | .03–12.0 | .03–5.9 | .05–16.4 |
| Median Dur (years) a | 1.0 | 11.3 | 1.1 | 9.7 | 16.7 | 3.6 | 1.0 | 1.0 | .8 | 2.3 |
| (5–95 %-tile) | .1–24.4 | .3–30.7 | .1–20.3 | .4–29.5 | 1.0–34.4 | .1–31.3 | .1–28.0 | .1–25.0 | .09–16.5 | .1–29.2 |
| Observed and expected deaths and SMRs for NPC | ||||||||||
| Obs | 6 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| SMR-US (Exp) | 5.44** (1.1) | 4.32 (.2) | 3.01 (.7) | - (.4) | - (.2) | - (1.1) | .93 (1.1) | - (.4) | - (.3) | 1.21 (.8) |
| (95 % CI) | 2–11.85 | .11–24.08 | .36–10.87 | 0–9.03 | 0–18.63 | 0–3.42 | .02–5.18 | 0–9.39 | 0–12.79 | .03–6.72 |
| SMR-local (Exp) | 5.57** (1.1) | 4.03 (.2) | 7.60 (.3) | - (.5) | - (.2) | - (1.3) | 1.24 (.8) | - (0) | - (.4) | 1.01 (1.0) |
| (95 % CI) | 2.04–12.12 | .10–22.48 | .92–27.46 | 0–7.30 | 0–21.09 | 0–2.82 | .03–6.89 | 0–90.04 | 0–10.14 | .03–5.63 |
aBased on exposed jobs only with no lag
** p < .01
Characteristics and findings for Plant 1 (Wallingford) and Plants 2-10 combined in 2004 NCI update
| Characteristic/finding | Plant 1 (Wallingford) | Plant 2–10 (all other plants) |
|---|---|---|
| Entry year | 1940 | 1934–1958 |
| No. subjects | 4261 | 21358 |
| Formaldehyde exposure | ||
| % Subjects ever exposed | 87.7 | 89.8 |
| % Subjects ever in highest peak category | 46.1 | 20.1 |
| Median AIE (ppm) a | 1.023 | 0.366 |
| (5–95 %-tile) | (.310–1.417) | (.052–1.257) |
| Median Cum (ppm-years) a | .9 | 3.2 |
| (5–95 %-tile) | (.1–17.2) | (.06–23.5) |
| Median Dur (years) a | 1.0 | 13.1 |
| (5–95 %-tile) | (.1–24.4) | (.3–32.1) |
| Observed deaths and SMRs | ||
|
| ||
| Observed deaths | 6 | 5 |
| SMR-US (expected deaths) | 5.44** (1.1) | .97 (5.2) |
| (95 % CI) | (2–11.85) | (.31–2.26) |
| SMR-local (expected deaths) | 5.57** (1.1) | 1.06 (4.7) |
| (95 % CI) | (2.04–12.12) | (.35–2.48) |
|
| ||
| Observed deaths | 6 | 3 |
| SMR-US (expected deaths) | 7.23** (.8) | .74 (4.1) |
| (95 % CI) | (2.65–15.74) | (.15–2.16) |
| SMR-local (expected deaths) | 7.34** (.8) | .82 (3.6) |
| (95 % CI) | (2.69–15.97) | (.17–2.41) |
|
| ||
| Observed deaths | 0 | 2 |
| SMR-US (expected deaths) | - (.3) | 1.81 (1.1) |
| (95 % CI) | (0–13.55) | (.22–6.53) |
| SMR-local (expected deaths) | - (.3) | 1.88 (1.1) |
| (95 % CI) | (0–14.20) | (.23–6.80) |
aBased on exposed jobs only with no lag
** p < .01
NCI FA cohort, NPC SMR results, local comparisons, by FA exposure, update and plant group
| Highest Peak Categorya | AIEb | Cumulative Exposure (Cum)b | Duration of Exposure (Dur)b | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metricc,d | 2004 NCI | 1994 NCI f | 2004 NCI | 1994 NCI f | Metricc,d | 2004 NCI | 1994 NCI f | 2004 NCI | 1994 NCI f | ||||||||||||||||
| Obs | SMRe | 95 % CI | Obs | SMRe | 95 % CI | Obs | SMRe | 95 % CI | Obs | SMRe | 95 % CI | Obs | SMRe | 95 % CI | Obs | SMRe | 95 % CI | Obs | SMRe | 95 % CI | Obs | SMRe | 95 % CI | ||
| All Plants | All Plants | ||||||||||||||||||||||||
| NCI Cats. | NCI Cats. | ||||||||||||||||||||||||
| Unexposed | 2 | 1.98 | (0.24–7.16) | 2 | 2.22 | (0.27–8.00) | 2 | 1.51 | (0.18, 5.46) | 2 | 1.62 | (0.20–5.84) | Unexposed | 2 | 1.51 | (0.18–5.46) | 2 | 1.62 | (0.20–5.84) | 2 | 1.51 | (0.18–5.46) | 2 | 1.62 | (0.20–5.84) |
| Exp Cat 1 | 1 | 1.03 | (0.03–5.73) | 0 | 0 | (0.00–2.46) | 1 | 0.41 | (0.01, 2.28) | 0 | -- | (0.00–1.77) | Exp Cat 1 | 4 | 1.50 | (0.41–3.83) | 3 | 1.36 | (0.28–3.97) | 5 | 1.83 | (0.59–4.26) | 4 | 1.80 | (0.49–4.62) |
| Exp Cat 2 | 0 | -- | (0.00, 2.24) | 0 | 0 | (0.00–3.47) | 1 | 0.91 | (0.02, 5.09) | 1 | 1.17 | (0.03–6.50) | Exp Cat 2 | 1 | 1.05 | (0.03–5.82) | 1 | 1.25 | (0.03–6.98) | 1 | 0.98 | (0.02–5.45) | 1 | 1.07 | (0.03–5.96) |
| Exp Cat 3 | 7 | 3.89** | (1.56–8.01) | 7 | 4.84** | (1.94–9.97) | 6 | 6.67** | (2.81, 14.42) | 6 | 8.36** | (3.07–18.21) | Exp Cat 3 | 3 | 3.75 | (0.77–10.96) | 3 | 4.57 | (0.94–13.37) | 2 | 2.86 | (0.35–10.32) | 2 | 3.94 | (0.48–14.25) |
| UPitt Cats. | UPitt Cats. | ||||||||||||||||||||||||
| Unexposed | 2 | 1.98 | (0.24–7.16) | 2 | 2.22 | (0.27–8.00) | 2 | 1.51 | (0.18, 5.46) | 2 | 1.62 | (0.20–5.84) | Unexposed | 2 | 1.51 | (0.18–5.46) | 2 | 1.62 | (0.20–5.84) | 2 | 1.51 | (0.18–5.46) | 2 | 1.62 | (0.20–5.84) |
| Exp Cat 1 | 1 | 1.03 | (0.03–5.73) | 0 | -- | (0.00–2.46) | 4 | 1.11 | (0.30, 2.83) | 3 | 0.99 | (0.20–2.90) | Exp Cat 1 | 4 | 1.86 | (0.51–4.77) | 3 | 1.69 | (0.35–4.94) | 3 | 2.32 | (0.48–6.77) | 3 | 2.88 | (0.40–8.43) |
| Exp Cat 2 | 0 | -- | (0.00, 2.24) | 0 | -- | (0.00–3.47) | 2 | 6.33 | (0.77, 22.86) | 2 | 7.60 | (0.92–27.46) | Exp Cat 2 | 2 | 1.08 | (0.13–3.89) | 2 | 1.30 | (0.16–4.68) | 3 | 1.83 | (0.38–5.36) | 2 | 1.49 | (0.18–5.38) |
| Exp Cat 3 | 8 | 4.50** | (1.94–8.87) | 8 | 5.53** | (2.39–10.90) | 3 | 5.73* | (1.18, 16.75) | 3 | 8.06* | (1.66–23.55) | Exp Cat 3 | 3 | 6.60* | (1.36–19.30) | 3 | 8.80* | (1.82–25.73) | 3 | 1.96 | (0.41–5.74) | 3 | 2.35 | (0.48–6.86) |
| Plant 1 | Plant 1 | ||||||||||||||||||||||||
| UPitt Cats. | UPitt Cats. | ||||||||||||||||||||||||
| Unexposed | 0 | -- | (0.00, 2.09) | 0 | 0 | (0.00–24.59) | 0 | -- | (0.00, 14.20) | 0 | -- | (0.00–15.97) | Unexposed | 0 | -- | (0.00–14.20) | 0 | -- | (0.00–15.97) | 0 | -- | (0.00–14.20) | 0 | -- | (0.00–15.97) |
| Exp Cat 1 | 0 | -- | (0.00, 2.90) | 0 | -- | -- | 2 | 4.88 | (0.59, 17.61) | 2 | 7.46 | (0.90–26.94) | Exp Cat 1 | 3 | 8.26* | (1.70–24.14) | 3 | 11.70** | (2.41–34.18) | 3 | 9.14** | (1.89–26.72) | 3 | 12.79** | (2.64–37.37) |
| Exp Cat 2 | 0 | -- | (0.00, 2.90) | 0 | -- | (0.00–13.54) | 2 | 10.74* | (1.30, 38.79) | 2 | 13.96* | (1.69–50.44) | Exp Cat 2 | 2 | 5.24 | (0.63–18.93) | 2 | 7.21 | (0.87–26.04) | 2 | 6.30 | (0.76–22.75) | 2 | 9.01* | (1.09–32.54) |
| Exp Cat 3 | 6 | 12.91** | (4.74–28.10) | 6 | 17.04** | (6.25–37.08) | 2 | 9.03* | (1.09, 32.64) | 2 | 11.78* | (1.43–42.57) | Exp Cat 3 | 1 | 13.66 | (0.34–76.10) | 1 | 21.18 | (0.53–118.03) | 1 | 5.80 | (0.15–32.34) | 1 | 8.03 | (0.20–44.75) |
| Plants 2–10 | Plants 2–10 | ||||||||||||||||||||||||
| UPitt Cats. | UPitt Cats. | ||||||||||||||||||||||||
| Unexposed | 2 | 2.42 | (0.29–8.75) | 2 | 2.66 | (0.32–9.60) | 2 | 1.88 | (0.23, 6.80) | 2 | 1.99 | (0.24–7.18) | Unexposed | 2 | 1.88 | (0.23–6.80) | 2 | 1.99 | (0.24–7.19) | 2 | 1.88 | (0.23–6.80) | 2 | 1.99 | (0.24–7.18) |
| Exp Cat 1 | 1 | 1.04 | (0.03–5.77) | 0 | -- | (0.00–2.46) | 2 | 0.62 | (0.08, 2.25) | 1 | 0.36 | (0.01–2.02) | Exp Cat 1 | 1 | 0.56 | (0.01–3.12) | 0 | -- | (0.00–2.43) | 0 | -- | (0.00–3.82) | 0 | -- | (0.00–4.58) |
| Exp Cat 2 | 0 | -- | (0.00, 2.90) | 0 | -- | (0.00–4.66) | 0 | -- | (0.00, 28.43) | 0 | -- | (0.00–30.78) | Exp Cat 2 | 0 | -- | (0.00–2.50) | 0 | -- | (0.00–2.92) | 1 | 0.76 | (0.02–4.23) | 0 | -- | (0.00–3.29) |
| Exp Cat 3 | 2 | 1.52 | (0.18–5.50) | 2 | 1.83 | (0.22–6.60) | 1 | 3.31 | (0.08, 18.45) | 1 | 4.94 | (0.12–27.50) | Exp Cat 3 | 2 | 5.25 | (0.64–18.96) | 2 | 6.81 | (0.82–24.61) | 2 | 1.48 | (0.18–5.33) | 2 | 1.73 | (0.21–6.26) |
aNCI categories based on 60 and 80th percentiles of formaldehyde exposure among cancer deaths who were exposed. Includes only 10/11 deaths
bUniversity of Pittsburgh categories based on approx. tertiles of formaldehyde exposure among NPC deaths who were exposed. Include 11 deaths
cAll exposures lagged 15 years as in NCI study
dNCI exposure category cutpoints: highest peak (>0- < 2.0, 2.0- < 4.0, and 4.0+ ppm); average intensity of exposure (>0-0.5, 0.5- < 1.0, and 1.0+ ppm); cumulative exposure (>0-1.5, 1.5- < 5.5, and 5.5+ ppm-years); duration of exposure (>0- < 5.0, 5.0- < 15.0, and 15.0+ years). UPitt exposure category cutpoints: highest peak (same as NCI) (>0- < 2.0, 2.0- < 4.0, and 4.0+ ppm); average intensity of exposure (<1.046, 1.046-1.177, and 1.178+ ppm); cumulative exposure (<0.734, 0.734-10.150, and 10.151+ ppm-years); duration of exposure (<0.617, 0.617-6.263, and 6.264+ years)
eAll SMRs adjusted for sex, race, age group, and time period
fFrom Marsh and Youk (2005)
*p < 0.05, **p < 0.01
Fig. 1a RRs and 95 % CIs by Highest Peak Formaldehyde Exposure, Exact Estimation, (from Additional file 1: Table S1a). b RRs and 95 % CIs by Average Intensity of Formaldehyde Exposure, Exact Estimation, (from Additional file 1: Table S1b)